LobbyingLupin Pharmaceuticals lobbying by quarter
Lupin Pharmaceuticals's latest lobbying report covers Q2 2026, at $134.8K. The four quarters Q4 2025–Q3 2026 total $471.8K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Lupin Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $471.8K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $136.3K | 1 |
| Q1 2023 | $136.3K | 1 |
| Q2 2023 | $136.3K | 1 |
| Q3 2023 | $105K | 1 |
| Q4 2023 | $75K | 1 |
| Q1 2024 | $84.6K | 1 |
| Q2 2024 | $114.2K | 1 |
| Q3 2024 | $114.2K | 1 |
| Q4 2024 | $114.2K | 1 |
| Q1 2025 | $80K | 2 |
| Q2 2025 | $155K | 2 |
| Q3 2025 | $169K | 3 |
| Q4 2025 | $202.8K | 3 |
| Q1 2026 | $134.3K | 2 |
| Q2 2026 | $134.8K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$336.6K · 19 reports
- Medicare and Medicaid$260.6K · 15 reports
- Pharmacy$260.6K · 15 reports
- Trade$254.4K · 10 reports
- Copyright, patent and trademark$159.6K · 9 reports
- Disaster planning and emergencies$159.6K · 9 reports
- Manufacturing$159.4K · 9 reports
- Tariffs$120K · 3 reports
- Science and technology$101.2K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE19 reports
- HOUSE OF REPRESENTATIVES15 reports
- U.S. Trade Representative (USTR)7 reports
- White House Office7 reports
- Commerce, Dept of (DOC)6 reports
- Health & Human Services, Dept of (HHS)4 reports
- State, Dept of (DOS)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseLupin Pharmaceuticals | $1.4M | 15 quarters |
| Ballard Partners | $320K | 4 quarters |
| Medsecurean.com | $152K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| SHAWN BROWN esq | VP Government Affairs. | Q2 2026 |
| HUNTER MORGEN | Policy Advisor, Office of Policy Planning, U.S. State Dept. (2017); Deputy Director, Office of Trade & Manufacturing Policy, WH (2017-2018); Special Assistant to the President, Office of the Senior Advisor for Policy, WH (2018-2020) | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/24for Q2 | In-house | $80.8K |
| 07/13for Q2 | Medsecurean.com | $54K |
| 07/13for Q1 | Medsecurean.com | $42K |
| 04/23for Q1 | In-house | $92.3K |
| 04/20for Q4 2025 | Ballard Partners | $80K |
| 02/14for Q4 2025 | Medsecurean.com | $42K |
| 01/20for Q4 2025 | In-house | $80.8K |
| 01/14for Q4 2025 | Ballard Partners | $80K |
| 25/10/27for Q3 2025 | In-house | $75K |
| 25/10/16for Q3 2025 | Ballard Partners | $80K |
| 25/09/22for Q3 2025 | Medsecurean.com | $14K |
| 25/09/21for Q1 2025 | Medsecurean.com | Under $5,000 |
| 25/08/19for Q4 2024 | In-house | $114.2K |
| 25/07/21for Q2 2025 | In-house | $75K |
| 25/07/16for Q2 2025 | Ballard Partners | $80K |
| 25/04/23for Q1 2025 | In-house | Under $5,000 |
| 25/04/16for Q1 2025 | Ballard Partners | $80K |
| 25/02/04for Q1 2025 | Ballard Partners | Under $5,000 |
| 24/11/07for Q3 2024 | In-house | $114.2K |
| 24/08/09for Q2 2024 | In-house | $114.2K |